GeneCopoeia OncoSpot Cancer Cell Lines

Friday, 01 June, 2018 | Supplied by: United Bioresearch Products Pty Ltd


Cancer cell lines

GeneCopoeia offers premade cancer cell lines carrying diverse gene mutations commonly seen in tumour biomarkers, including EGFR, KRAS and BRAF in the MAPK pathway.

The mutant cells are engineered based on the HCT116 cancer cell line, in which mutations are integrated either homozygously or heterozygously using CRISPR technology. They can be used to enhance our understanding of cancer biology and the development of cancer therapies, either as cell line models for the study of metabolic and signalling pathways or as in vitro models for drug screening and toxicity studies.

The cell lines feature puromycin resistance for easy growth and maintenance. Mutations are available in both homozygous and heterozygous forms. Premade cell lines are available for next-day shipping; a custom cell line service is also available.

For more information: http://www.genecopoeia.com/product/cell-biology-product/cancer-mutant-cell-lines/.

Online: www.unitedbioresearch.com.au
Phone: 02 4575 0309
Related Products

Integrated DNA Technologies rhAmpSeq targeted sequencing system

Integrated DNA Technologies (IDT) introduces its rhAmpSeq targeted sequencing system, providing...

Lonza Verified for Spheroids Human Hepatocytes

Lonza has expanded its hepatocytes portfolio characterisation with the addition of Verified for...

AdipoGen PD-1/PD-L1 ELISA Kits

AdipoGen has released PD-1/PD-L1 (Programmed Cell Death Protein-1/Programmed Cell Death Ligand-1)...


  • All content Copyright © 2019 Westwick-Farrow Pty Ltd